Corrigendum to "Development of SARS-CoV-2 Inhibitors Using Molecular Docking Study with Different Coronavirus Spike Protein and ACE2” [J Mol Docking. 2021;1(2):1-14]

Authors

DOI:

https://doi.org/10.33084/jmd.v1i2.3063

Keywords:

Corrigendum

Abstract

Authors have found an error in the previous version (Shamkh, IM, & Pratiwi, D. (2021). Development of SARS-CoV-2 Inhibitors Using Molecular Docking Study with Different Coronavirus Spike Protein and ACE2. Journal of Molecular Docking, 1(1), 1-14. https://doi.org/10.33084/jmd.v1i1.2212), of which Dr. Hanaa S. Omar as supervisor of the research, is not listed as one of the authors. In this note, Dr. Hanaa S. Omar was added as one of the authors, with the status of the corresponding author in the study.

Downloads

Download data is not yet available.

References

1. Shamkh IM, Pratiwi D. Development of SARS-CoV-2 Inhibitors Using Molecular Docking Study with Different Coronavirus Spike Protein and ACE2. J Mol Docking. 2021;1(1):1-14. doi:10.33084/jmd.v1i1.2212

Downloads

Published

2021-12-30

How to Cite

1.
Shamkh IM, Pratiwi D, Omar HS. Corrigendum to "Development of SARS-CoV-2 Inhibitors Using Molecular Docking Study with Different Coronavirus Spike Protein and ACE2” [J Mol Docking. 2021;1(2):1-14]. J Mol Docking [Internet]. 2021Dec.30 [cited 2024Mar.29];1(2):48. Available from: https://journal.umpr.ac.id/index.php/jmd/article/view/3063